Skip to main content
Log in

Role of Leukotriene Antagonists and Antihistamines in the Treatment of Allergic Rhinitis

  • RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Allergic rhinitis is the most common atopic disorder seen in ENT clinics. It is diagnosed by history, physical exam and objective testing. Patient education, environmental control measures, pharmacotherapy, and allergen-specific immunotherapy are the cornerstones of allergic rhinitis treatment and can significantly reduce the burden of disease. Current treatment guidelines include antihistamines, intranasal corticosteroids, oral and intranasal decongestants, intranasal anticholinergics, intranasal cromolyn, and leukotriene receptor antagonists. In the mechanism of allergic rhinitis, histamine is responsible for major allergic rhinitis symptoms such as rhinorrhea, nasal itching and sneezing. Its effect on nasal congestion is less evident. In contrast, leukotrienes result in increase in nasal airway resistance and vascular permeability. Antihistamines and leukotriene receptor antagonists are commonly used in the treatment of allergic rhinitis. The published literature about combined antihistamines and leukotriene antagonists in mono- or combination therapy is reviewed and presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Valk PJ, Simons M. Effects of loratadine/montelukast on vigilance and alertness task performance in a simulated cabin environment. Adv Ther. 2009;26(1):89–98.

    Article  PubMed  CAS  Google Scholar 

  2. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8–160.

    Article  PubMed  Google Scholar 

  3. Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000;105(5):917–22.

    Article  PubMed  CAS  Google Scholar 

  4. Cingi C, Kayabasoglu G, Nacar A. Update on the medical treatment of allergic rhinitis. Inflamm Allergy Drug Targets. 2009;8(2):96–103.

    Article  PubMed  CAS  Google Scholar 

  5. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12.

    PubMed  Google Scholar 

  6. Van Hoecke H, Vandenbulcke L, Van Cauwenberge P. Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis: an update. Drugs. 2007;67(18):2717–26.

    Article  PubMed  Google Scholar 

  7. Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, et al. Sub-lingual immunotherapy: World Allergy Organization position paper 2009. Allergy. 2009;64 Suppl 91:1–59.

    PubMed  Google Scholar 

  8. Lagos JA, Marshall GD. Montelukast in the management of allergic rhinitis. Ther Clin Risk Manag. 2007;3(2):327–32.

    Article  PubMed  CAS  Google Scholar 

  9. Al Suleimani YM, Walker MJ. Allergic rhinitis and its pharmacology. Pharmacol Ther. 2007;114(3):233–60.

    Article  PubMed  Google Scholar 

  10. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.

    Article  PubMed  CAS  Google Scholar 

  11. Lambrecht BN. Allergen uptake and presentation by dendritic cells. Curr Opin Allergy Clin Immunol. 2001;1(1):51–9.

    PubMed  CAS  Google Scholar 

  12. Takhar P, Corrigan CJ, Smurthwaite L, O’Connor BJ, Durham SR, Lee TH, et al. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol. 2007;119(1):213–8.

    Article  PubMed  CAS  Google Scholar 

  13. Grønborg H, Bisgaard H, Rømeling F, Mygind N. Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticosteroid spray. Allergy. 1993;48(2):87–93.

    Article  PubMed  Google Scholar 

  14. Min YG. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2010;2(2):65–76.

    Article  PubMed  Google Scholar 

  15. Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. Int Immunopharmacol. 2011;11(11):1646–62.

    Article  PubMed  CAS  Google Scholar 

  16. Smith LJ. Pharmacology and safety of the leukotriene antagonists. Clin Rev Allergy Immunol. 1999;17(1–2):195–212.

    Article  PubMed  CAS  Google Scholar 

  17. Venarske D, de Shazo RD. Molecular mechanisms of allergic disease. South Med J. 2003;96(11):1049–54.

    Article  PubMed  Google Scholar 

  18. Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J Clin Investig. 1995;95(1):264–71.

    Article  PubMed  CAS  Google Scholar 

  19. Taylor-Clark T, Foreman J. Histamine-mediated mechanisms in the human nasal airway. Curr Opin Pharmacol. 2005;5(3):214–20.

    Article  PubMed  CAS  Google Scholar 

  20. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol. 1990;86(6 Pt 1):924–35.

    Article  PubMed  CAS  Google Scholar 

  21. Baroody FM, Naclerio RM. Antiallergic effects of H1-receptor antagonists. Allergy. 2000;55(64):17–27.

    Article  PubMed  Google Scholar 

  22. Nakaya M, Takeuchi N, Kondo K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann Otol Rhinol Laryngol. 2004;113(7):552–7.

    PubMed  Google Scholar 

  23. Akdis CA, Blaser K. Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol. 2003;112(1):15–22.

    Article  PubMed  CAS  Google Scholar 

  24. Camelo-Nunes IC. Newantihistamines: a critical view. J Pediatr (Rio J). 2006;82(5):S173–80.

    Article  Google Scholar 

  25. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–76.

    Article  PubMed  Google Scholar 

  26. Cingi C, Gunhan K, Gage-White L, Unlu H. Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis. Laryngoscope. 2010;120(9):1718–23.

    Article  PubMed  CAS  Google Scholar 

  27. Lee C, Corren J. Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis. Expert Opin Pharmacother. 2007;8(5):701–9.

    Article  PubMed  CAS  Google Scholar 

  28. Canonica GW, Ciprandi G, Petzold U, Kolb C, Ellers-Lenz B, Hermann R. Topicalazelastine in perennial allergic conjunctivitis. Curr Med Res Opin. 2003;19(4):321–9.

    Article  PubMed  CAS  Google Scholar 

  29. Murphy RC, Hammarström S, Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A. 1979;76(9):4275–9.

    Article  PubMed  CAS  Google Scholar 

  30. Peters-Golden M, Gleason MM, Togias A. Cysteinylleukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy. 2006;36(6):689–703.

    Article  PubMed  CAS  Google Scholar 

  31. Haberal I, Corey JP. The role of leukotrienes in nasal allergy. Otolaryngol Head Neck Surg. 2003;129(3):274–9.

    Article  PubMed  Google Scholar 

  32. Peters-Golden M, Henderson Jr WR. The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol. 2005;94(6):609–18.

    Article  PubMed  CAS  Google Scholar 

  33. Busse W, Kraft M. Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest. 2005;127(4):1312–26.

    Article  PubMed  CAS  Google Scholar 

  34. Elnabtity MH, Singh RF, Ansong MA, Craig TJ. Leukotriene modifiers in the management of asthma. J Am Osteopath Assoc. 1999;99(7):S1–6.

    PubMed  CAS  Google Scholar 

  35. Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Drugs. 2007;67(6):887–901.

    Article  PubMed  CAS  Google Scholar 

  36. Grainger J, Drake-Lee A. Montelukast in allergic rhinitis: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31(5):360–7.

    Article  PubMed  CAS  Google Scholar 

  37. Samaria JK. Anti leukotriene drugs: are they really useful? J Indian Acad Clin Med. 2000;5(1):41–4.

    Google Scholar 

  38. Kurowski M, Kuna P, Górski P. Montelukastpluscetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation. Allergy. 2004;59(3):280–8.

    Article  PubMed  CAS  Google Scholar 

  39. Ciebiada M, Ciebiada MG, Kmiecik T, DuBuske LM, Gorski P. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. J Investig Allergol Clin Immunol. 2008;18(5):343–9.

    PubMed  CAS  Google Scholar 

  40. Watanasomsiri A, Poachanukoon O, Vichyanond P. Efficacy of montelukast and loratadine as treatment for allergic rhinitis in children. Asian Pac J Allergy Immunol. 2008;26(2–3):89–95.

    PubMed  CAS  Google Scholar 

  41. Day JH, Briscoe MP, Ratz JD, Ellis AK, Yao R, Danzig M. Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. Allergy Asthma Proc. 2009;30(3):270–6.

    Article  PubMed  CAS  Google Scholar 

  42. Pullerits T, Praks L, Ristioja V, Lötvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2002;109(6):949–55.

    Article  PubMed  CAS  Google Scholar 

  43. Di Lorenzo G, Pacor ML, Pellitteri ME, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasonepluscetirizine, fluticasoneplus montelukast and cetirizineplus montelukast for seasonal allergic rhinitis. Clin Exp Allergy. 2004;34(2):259–67.

    Article  PubMed  Google Scholar 

  44. Rodrigo GJ, Yañez A. The role of anti leukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol. 2006;96(6):779–86.

    Article  PubMed  CAS  Google Scholar 

  45. Lee DK, Jackson CM, Soutar PC, Fardon TC, Lipworth BJ. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis. Br J Clin Pharmacol. 2004;57(6):714–9.

    Article  PubMed  CAS  Google Scholar 

  46. Hay J, Jhaveri M, Tangirala M, Kaliner M. Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment. Allergy Asthma Proc. 2009;30(6):634–42.

    Article  PubMed  Google Scholar 

  47. Scadding GW, Scadding GK. Recent advances in antileukotriene therapy. Curr Opin Allergy Clin Immunol. 2010;10(4):370–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bengü Çobanoğlu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Çobanoğlu, B., Toskala, E., Ural, A. et al. Role of Leukotriene Antagonists and Antihistamines in the Treatment of Allergic Rhinitis. Curr Allergy Asthma Rep 13, 203–208 (2013). https://doi.org/10.1007/s11882-013-0341-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-013-0341-4

Keywords

Navigation